相关实验视频

Updated: May 6, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

与移植后结果相关的捐赠者IL-10和FOXP3单核酸多态

Hirotaro Sakaki¹, Misuzu Sato², Mami Umemoto¹

¹Division of Hematology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.

Leukemia & lymphoma

|August 25, 2025

概括

捐赠基因FOXP3和IL-10的变异影响了全源造血干细胞移植 (allo-HSCT) 的结果. 在带血移植 (UCBT) 中,特定的基因型与更差的存活率和更高的慢性移植对宿主疾病 (GVHD) 有关.

科学领域:

免疫学
移植医学
遗传学

背景情况:

异构造血干细胞移植 (allo-HSCT) 是血液恶性瘤的治疗选择.
移植对宿主疾病 (GVHD) 和免疫失调是移植后的重大并发症.
调节性T细胞 (Tregs) 和IL-10对免疫耐受性至关重要.

研究的目的:

调查FOXP3和IL-10中的捐赠单核酸多态 (SNPs) 与alo-HSCT接受者的临床结果之间的关联.
专门评估这些SNP在带血移植 (UCBT) 的影响.
评估这些遗传标记在UCBT中的风险分层的潜力.

主要方法:

对92名allo-HSCT接受者的回顾性分析.
提供者FOXP3-3279 (rs3761548) 和IL-10-819 (rs1800871) 的SNP的基因定型.
基因型与无进展生存率,总生存率和GVHD发生率的相关性.

主要成果:

在UCBT接受者中,非C/ CFOXP3和非T/ TIL-10捐赠者基因型与明显较差的无进展和整体存活率有关.
这些基因型与UCBT接受者的慢性GVHD发病率较高相关.
多变量分析证实了这些SNP的独立预后价值.

结论:

捐赠者衍生SNP在FOXP3和IL-10可能影响免疫复制和alo-HSCT后的临床结果,特别是UCBT.
FOXP3和IL-10基因定型可以作为宝贵的生物标志物用于供体选择和风险分层.
这种遗传信息可能有助于优化移植策略并改善患者的治疗结果.

关键词:

全源造血干细胞移植其他类型一个IL-10 移植对宿主疾病一个核酸多态

更多相关视频

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...